Clinical Trials Browser

Phase 2 × Breast Neoplasms × LHRH, lysine(6)-doxorubicin × Clear all

NCT01698281 2018-02-22

Phase 2 Trial of AEZS-108 in Chemotherapy Refractory in Triple Negative Breast Cancer

Phase 2 Terminated

Breast Neoplasms